The Food and Drug Administration (FDA) carried out an inspection for foodborne biological hazards at Axxence Production in Oakdale on May 1, according to information posted on the FDA’s website.
The resulting report stated that Axxence Production was not required to make any changes to its management operations.
Across the country, the FDA regularly inspects facilities to make sure workplaces and products meet agency laws and regulations for public health protection. Inspection outcomes are made available to the public.
As described on its website, the FDA is a government agency mainly tasked with overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco items.
Information for this report was sourced from the U.S. Food and Drug Administration. Original source data is available here.
